Crowdonomics
WatchlistPortfolio
Ortek Therapeutics

Reg CF · Common Stock · May 2022

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$62.6K / $1.1M max
6% of ceiling · target hit day 3
Investors
78
$1.5K avg
Post-money valuation
$22.8M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$115K$58K$0
78390
May 13, 2022 · openedSep 7, 2022 · last reading
Target ($10K) hit — May 16, 2022, day 3Deadline Sep 6, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$2.1M
−$230K
FY2020
$445K
−$615K
FY2021
RevenueNet income
Metric
FY2020 reviewed*
FY2021 unaudited
Income statement
Revenue
$2,145,578
$445,252
Cost of goods sold
$1,174,308
$112,341
Gross margin
45%
75%
Net income
-$230,189
-$614,548
Taxes paid
$0
$0
Balance sheet
Cash
$1,547,649
$981,561
Accounts receivable
$931,347
$0
Total assets
$2,014,889
$1,406,235
Short-term debt
$22,638
$0
Long-term debt
$0
$0
Total liabilities
$22,638
$0
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Aug 5, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$22.7M
Post-money$22.8M
Price / share$1.00
Shares offered10,000

Perks

Invest $250+ within the first week and receive 20% bonus shares · until May 19, 202220% bonus$250+

Offering details

Target$10,000
Max$1,070,000
Min investment$250
OpenedMay 13, 2022
DeadlineSep 6, 2022
ClosedSep 6, 2022
Days active116

Links & provenance

Campaign pagePitch videoSEC filingStartEngine listing
Source: Manual
0001665160-22-001605
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.